Academic Specialist Center

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Multiple sclerosis

Running trials

• Active, not recruiting

  Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

  NCT06700343· Phase 3· Amgen· Source